Nexavar shows promise in acute myeloid leukemia
January 30, 2008 — CHICAGO (Reuters) - The kidney cancer pill Nexava, know generically as sorafenib, has shown promise in treating a small number of people with a type of blood cancer known as acute myeloid leukemia, or AML, U.S. researchers said on Tuesday.
Select news items provided by Reuters Health